Projects per year
Fingerprint
Dive into the research topics where Christine H O'Connor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects and Grants
- 1 Finished
-
DISSERTATION RESEARCH: Interaction of gene flow, selection and genomic architecture on the genetics of adaptation
Phillips, P. P. C. & O'Connor, C. H.
6/1/16 → 5/31/18
Project: Research project
-
Stat5 induces androgen receptor (AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling
Maranto, C., Sabharwal, L., Udhane, V., Pitzen, S. P., McCluskey, B., Qi, S., O’Connor, C., Devi, S., Johnson, S., Jacobsohn, K., Banerjee, A., Iczkowski, K. A., Wang, L., Dehm, S. M. & Nevalainen, M. T., Mar 2024, In: Science Advances. 10, 9, eadi2742.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors (Scientific Reports, (2023), 13, 1, (5349), 10.1038/s41598-023-32321-0)
Bapat, A. S., O’Connor, C. H. & Schwertfeger, K. L., Dec 2023, In: Scientific reports. 13, 1, 16689.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
Bapat, A. S., O’Connor, C. H. & Schwertfeger, K. L., Dec 2023, In: Scientific reports. 13, 1, 5349.Research output: Contribution to journal › Article › peer-review
Open Access -
Type III interferon drives thymic B cell activation and regulatory T cell generation
Martinez, R. J., Breed, E. R., Worota, Y., Ashby, K. M., Vobořil, M., Mathes, T., Salgado, O. C., O’Connor, C. H., Kotenko, S. V. & Hogquist, K. A., Feb 28 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 9, e2220120120.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation
Yang, J., Liao, Q., Price, M., Moriarity, B., Wolf, N., Felices, M., Miller, J. S., Geller, M. A., Bendzick, L., Hopps, R., Starr, T. K., O'Connor, C. H., Tarullo, S., Nelson, A. C., Turley, E., Wang, J. & McCarthy, J. B., Feb 2022, In: Translational Oncology. 16, 101318.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations